The consulting firm Prohibition Partners expects Europe to grow into the world's largest market for legal cannabis products in the next five years. Germany will become by far the largest market for medical cannabis products. According to the experts, Europe will thus overtake the North American market.
Cannabis has arrived in society
The cannabis boom of recent years is leading to changes in the legal system in more and more countries to provide medical and economic opportunities. The
commercialization of a new product universe of different brands and unique selling points will continue to change the medical sector in the coming years.
More and more people accept cannabis as
medical product and its use will become a part of modern society.
Internet as knowledge platform
The Internet as a media platform has driven the process of
legalization of cannabis for treatments. The experience of adults and children in dealing with medical cannabis could no longer be controlled by the conventional press and success stories spread virally in the social media.
Further education with first-hand information and the publication of scientific studies has allowed the process of
decriminalization to move forward. The number of opponents of legalization in the USA fell from 52% in 2010 to just 32% in November 2019, according to the Pew Research Centre.
EXMceuticals with focus on Europe
The
change of mind in society was supported by the use of CBD in trendy consumer goods, among other things. CBD can now be found in a variety of beverages and food products. In addition, this ingredient is also increasingly used in body care and beauty products. Antioxidants and the anti-inflammatory properties ensure that the products are becoming increasingly popular.
Investors who would like to participate in this development should take a closer look at the shares of Aphria (TSX: APHA), Canopy Growth (TSX: WEED) and EXMceuticals (CSE: EXM). While the two giants Aphria and Canopy Growth have positioned themselves globally, EXMceuticals focuses on the European market from Portugal.
CONFLICT OF INTEREST & RISK NOTE
We would like to point out that Apaton Finance GmbH, the owner of news.financial, as well as partners, authors or employees of Apaton Finance GmbH may hold shares in the aforementioned companies and that there may therefore be a conflict of interest. Further details can be found in our ´
Conflict of Interest & Risk Disclosure´.